OpenAI CEO Sam Altman Urges Senate Committee to Treat ChatGPT as a Tool, Not a Creature

Date:

In recent times, the increasing usage of Artificial Intelligence (AI) has generated much debate around the globe, especially in the US where discussions about a potential regulatory framework for AI are underway. As part of this discussion, OpenAI’s CEO, Sam Altman, recently testified before a Senate Judiciary Committee about the company’s chatbot, ChatGPT.

Altman stressed upon the important role that AI can play in augmenting human progress and urged the senators to treat ChatGPT and similar tools more like a tool and less like a creature. He also added that while regulation is naturally needed in such cases, completely blocking innovation in this field may not be the right course of action.

OpenAI is an American technology company based in San Francisco, California, founded by Elon Musk, Sam Altman, Greg Brockman, and others in late 2015. It is worth mentioning that AI is one of the company’s main focus areas, with ChatGPT being their most recent and successful project. As the co-founder and CEO of OpenAI, Sam Altman is considered one of the foremost experts in the field of AI and its applications. Over the course of his career, he has demonstrated a deep understanding of AI and its implications while also advocating for its responsible and regulated usage.

See also  Generate Windows 11 and Windows 10 Pro Keys with ChatGPT and Google Bard

Frequently Asked Questions (FAQs) Related to the Above News

Please note that the FAQs provided on this page are based on the news article published. While we strive to provide accurate and up-to-date information, it is always recommended to consult relevant authorities or professionals before making any decisions or taking action based on the FAQs or the news article.

Share post:

Subscribe

Popular

More like this
Related

Obama’s Techno-Optimism Shifts as Democrats Navigate Changing Tech Landscape

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.